Leaflet EPLOHART 50mg film-coated tablets

Indicated for: hypertension

Route of administration: oral

Substance: eplerenone (diuretic)

ATC: C03DA04 (Cardiovascular system | Potassium-sparing agents | Aldosterone antagonists)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Eplerenone is a medication mainly used to treat heart failure and high blood pressure. It works by blocking the effects of the hormone aldosterone, helping to remove excess salt and water from the body and thus reducing the strain on the heart. Eplerenone is usually taken as tablets, as prescribed by the doctor.

Treatment with eplerenone requires careful monitoring of potassium levels and kidney function, as electrolyte imbalances may occur. It is important for patients to follow the prescribed dose and have regular blood tests.

Side effects may include increased potassium levels in the blood, dizziness, fatigue, or digestive disturbances. In rare cases, allergic reactions or impaired kidney function may occur.

Eplerenone is an effective medication for patients with heart failure or high blood pressure, but it requires constant medical supervision to prevent complications. Collaboration with the doctor is essential for treatment success.

General data about EPLOHART 50mg

  • Substance: eplerenone
  • Date of latest medicines list: 01-01-2015
  • Product code: W61254001
  • Concentration: 50mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 20
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: LABORATORIOS LICONSA, S.A. - SPANIA
  • Holder: STADA HEMOFARM SRL - ROMANIA
  • Number: 9289/2016/02
  • Shelf life: 3 years

Concentrations available for eplerenone

  • 25mg
  • 50mg